Текст книги "Респираторная медицина. Руководство (в 2-х томах)"

Автор книги: А. Чучалин

сообщить о нарушении

Текущая страница: 157 (всего у книги 191 страниц)

29.Suratt PM, Dee P, Atkinson RL, et al: Fluoroscopic and computed tomographic features of the pharyngeal airway in obstructive sleep apnea. Am Rev Respir Dis 127:487-492, 1983.

30.Hudgel DW: Variable site of airway narrowing among obstructive sleep apnea patients. J Appl Physiol 61:1403-1409, 1986.

31.Guilleminault C, Stoohs R, Clerk A, et al: Cause of excessive daytime sleepiness: The upper airway resistance syndrome. Chest 104:781-787, 1993.

32.Guilleminault C, Beck J, Carillo O: EEG arousal and upper airway resistance syndrome. Electroencephalogr Clin Neurophysiol 103:501, 1999.

33.Bradley TD, Phillipson EA: Pathogenesis and pathophysiology of the obstructive sleep apnea syndrome. Med Clin North Am 69:1169-1185, 1985.

34.Malhotra A, White DP: Pathogenesis of obstructive sleep apnea syndrome. In McNicholas WT, Phillipson EA (eds): Breathing Disorders in Sleep. London: WB Saunders, 2002, pp 441-463.

35.Remmers JE, de Groot WJ, Sauerland EK, et al: Pathogenesis of upper airway occlusion during sleep. J Appl Physiol 44:931-938, 1978.

36.Smith PL, Wise RA, Gold AR, et al: Upper airway pressure-flow relationships in obstructive sleep apnea. J Appl Physiol 64:789-795, 1988.

37.Schwartz AR, Smith PL, Wise RA, et al: Effect of positive nasal pressure on upper airway pressure-flow relationships. J Appl Physiol 66:1626-1634, 1989.

38.Bear SE, Priest JH: Sleep apnea syndrome: Correction with surgical advancement of the mandible. J Oral Maxillofac Surg 35:543-549, 1980.

39.Mezon BJ, West P, Maclean JP, et al: Sleep apnea in acromegaly. Am J Med 69:615-618, 1980.

40.Orr WC, Martin RJ: Obstructive sleep apnea associated with tonsillar hypertrophy in adults. Arch Intern Med 141:990-992, 1981.

41.Haponik EF, Smith PL, Bohlman ME, et al: Computerized tomography in obstructive sleep apnea. Am Rev Respir Dis 127:221-226, 1983.

42.Riley R, Guilleminault C, Herran J, et al: Cephalometric analyses and flow-volume loops in obstructive sleep apnea patients. Sleep 6:303-311, 1983.

43.Rivlin J, Hoffstein V, Kalbfleisch J, et al: Upper airway morphology in patients with idiopathic obstructive sleep apnea. Am Rev Respir Dis 129:355-360, 1984.

44.Lowe AA, Gionhaker N, Takeuchi K, et al: Three dimensional CT reconstructions of tongue and airway in adult subjects with obstructive sleep apnea. Am J Orthod Dentofacial Orthop 90:364-374, 1986.

45.Horner RL, Mohiaddin RH, Lowell DG, et al: Sites and sizes of fat deposits around the pharynx in obese patients with obstructive sleep apnoea and weight matched controls. Eur Respir J 2:613-622, 1989.

46.Schwab RJ, Pasirstein M, Pierson R, et al: Identification of upper airway anatomic risk factors for obstructive sleep apnea with volumetric magnetic resonance imaging. Am J Respir Crit Care Med 168:522-530, 2003.

47.Davies RJO, Stradling JR: The relationship between neck circumference, radiographic pharyngeal anatomy, and the obstructive sleep apnea syndrome. Eur Respir J 3:509-514, 1990.

48.Issa FG, Sullivan CE: Upper airway closing pressures in obstructive sleep apnea. J Appl Physiol 57:520-527, 1984.

49.Brown IG, Bradley TD, Phillipson EA, et al: Pharyngeal compliance in snoring subjects with and without obstructive sleep apnea. Am Rev Respir Dis 132:211-215, 1985.

50.Bradley TD, Brown IG, Grossman RF, et al: Pharyngeal size in snorers, non-snorers, and patients with obstructive sleep apnea. N Engl J Med 315:1327-1331, 1986.

51.Mezzanotte WS, Tangel DJ, White DP: Waking genioglossal electromyogram in sleep apnea patients versus normal controls (a neuromuscular compensatory mechanism). J Clin Invest 89:1571-1579, 1992.

52.Hendricks JC, Petrof BL, Panckeri K, et al: Compensatory hyperactivity of an upper airway dilator in bulldogs. Am Rev Respir Dis 148:185-194, 1993.

53.Sauerland EK, Harper RM: The human tongue during sleep: Electromyographic activity of the genioglossus muscle. Exp Neurol 51:160-170, 1976.

54.Wheatley JR, Mezzanote WS, Tangel DJ, et al: Influence of sleep on genioglossus muscle activation by negative pressure in normal men. Am Rev Respir Dis 148:597-605, 1993.

55.Onal E, Lopata M, O'Connor T: Pathogenesis of apneas in hypersomnia-sleep apnea syndrome. Am Rev Respir Dis 125:167-174, 1982.

56.Onal E, Lopata M: Periodic breathing and the pathogenesis of occlusive sleep apneas. Am Rev Respir Dis 126:676-680, 1982.

57.Cherniack NS: Sleep apnea and its causes. J Clin Invest 73:150-156, 1984.

58.Hudgel DW, Chapman KR, Faulks C, et al: Changes in inspiratory muscle electrical activity and upper airway resistance during periodic breathing induced by hypoxia during sleep. Am Rev Respir Dis 135:899-906, 1987.

59.Parisi RA, Neubauer JA, Frank MM, et al: Correlation between genioglossal and diaphragmatic responses to hypercapnia during sleep. Am Rev Respir Dis 135:378-382, 1987.

60.Hudgel DW, Harasick T: Fluctuations in timing of upper airway and chest wall inspiratory muscle activity in obstructive sleep apnea. J Appl Physiol 69:443-450, 1990.

61.Taasan VC, Block AJ, Boysen PG, et al: Alcohol increases sleep apnea and oxygen desaturation in asymptomatic men. Am J Med 71:240-245, 1981.

62.Dolly FR, Block AJ: Effect of flurazepam on sleep-disordered breathing and nocturnal oxygen desaturation in asymptomatic subjects. Am J Med 73:239-243, 1982.

63.Issa FG, Sullivan CE: Alcohol, snoring and sleep apnea. J Neurol Neurosurg Psychiatry 45:353-359, 1982.

64.Krol RC, Knuth SL, Bartlett D Jr: Selective reduction of genio-glossal muscle activity by alcohol in normal human subjects. Am Rev Respir Dis 129:247-250, 1984.

65.Martin RJ, Pennock BE, Orr WC, et al: Respiratory mechanics and timing during sleep in occlusive sleep apnea. J Appl Physiol 48:432-437, 1980.

66.Vincken W, Guilleminault C, Silvestri L, et al: Inspiratory muscle activity as a trigger causing the airways to open in obstructive sleep apnea. Am Rev Respir Dis 135:372-377, 1987.

67.Yasuma F, Kozar LF, Kimoff RJ, et al: Interaction of chemical and mechanical respiratory stimuli in the arousal response to hypoxia in sleeping dogs. Am Rev Respir Dis 143:1274-1277, 1991.

68.Bowes G, Townsend ER, Bromley SM, et al: Role of the carotid body and of afferent vagal stimuli in the arousal response to airway occlusion in sleeping dogs. Am Rev Respir Dis 123:644-647, 1981.

69.Sullivan CE, Issa FG, Berthon-Jones M, et al: Pathophysiology of sleep apnea. In Saunders NA, Sullivan CE (eds): Lung Biology in Health and Disease. Vol 21: Sleep and Breathing. New York: Marcel Dekker, 1984, pp 299-363.

70.Bowes G, Woolf GM, Sullivan CE, et al: Effect of sleep fragmentation on ventilatory and arousal responses of sleeping dogs to respiratory stimuli. Am Rev Respir Dis 122:899-908, 1980.

71.Guilleminault C, Rosekind M: The arousal threshold: Sleep deprivation, sleep fragmentation, and obstructive sleep apnea syndrome. Bull Eur Physiopathol Respir 17:341-349, 1981.

72.Flemons WW, Whitelaw WA: Clinical features of obstructive sleep apnea syndrome. In McNicholas WT, Phillipson EA (eds): Breathing Disorders in Sleep. London: WB Saunders, 2002, pp 64-85.

73.George CF, Nickerson PW, Hanly PJ, et al: Sleep apnoea patients have more automobile accidents. Lancet 2:447, 1987.

74.Findley L, Fabrizio M, Thommi G, et al: Severity of sleep apnea and automobile crashes. N Engl J Med 320:868-869, 1989.

75.Barbe F, Pericas J, Munoz A, et al: Automobile accidents in patients with sleep apnea syndrome. Am J Respir Crit Care Med 158:18-22, 1998.

76.Teran-Santos J, Jiminez-Gomez A, Cordero-Guevara J: The association between sleep apnea and the risk of traffic accidents. N Engl J Med 340:847-851, 1999.

77.Telakivi T, Kajaste S, Partinen M, et al: Cognitive function in middle-aged snorers and controls: Role of excessive daytime somnolence and sleep related hypoxic events. Sleep 11:454-462, 1988.

78.Bedard MA, Montplaisir J, Richer F, et al: Obstructive sleep apnea syndrome: Pathogenesis of neuropsychological deficits. Clin Exp Neuropsychol 13:950-964, 1991.

79.Naegele B, Thouvard V, Pepin JL, et al: Deficits of cognitive executive functions in patients with sleep apnea syndrome. Sleep 18:43-52, 1995.

80.Lavie P: Pro: Sleep apnea causes cardiovascular disease. Am J Respir Crit Care Med 169:147-148, 2004.

81.Stradling J: Con: Sleep apnea does not cause cardiovascular disease. Am J Respir Crit Care Med 169:148-149, 2004.

82.Young T, Peppard P, Palta M, et al: Population-based study of sleep-disordered breathing as a risk factor for hypertension. Arch Intern Med 157:1746-1752, 1997.

83.Nieto FJ, Young TB, Lind BK, et al: Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 283:1829-1836, 2000.

84.Pepparad PE, Young T, Palta M, et al: Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med 342:1378-1384, 2000.

85.Kales A, Cadieux RJ, Shaw LC III, et al: Sleep apnoea in a hypertensive population. Lancet 2:1005-1008, 1984.

86.Fletcher ED, DeBehnke RD, Lovoi MS, et al: Undiagnosed sleep apnea in patients with essential hypertension. Ann Intern Med 103:190-195, 1985.

87.Worsnop CJ, Naughton MT, Barter CE, et al: The prevalence of sleep apnea in hypertensives. Am J Respir Crit Care Med 157:111-115, 1998.

88.Logan AG, Perlikowski SM, Mente A, et al: High prevalence of obstructive sleep apnea in drug resistant hypertension. J Hypertens 19:2271-2277, 2001.

89.Shahar E, Whitney CW, Redline S, et al: Sleep-disordered breathing and cardiovascular disease: Cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 163:19-25, 2001.

90.Marin JM, Carrizo SJ, Vicente E et al: Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study. Lancet 365:1046-1053, 2005

91.Hedner J, Ejnell H, Sellgren J, et al: Is high and fluctuating muscle nerve sympathetic activity in the sleep apnoea syndrome of pathogenetic importance for the development of hypertension? J Hypertens 6(Suppl 4):S529-S531, 1988.

92.Morgan BJ, Denahan T, Ebert TJ: Neurocirculatory consequences of negative intrathoracic pressure vs. asphyxia during voluntary apnea. J Appl Physiol 74:2969-2975, 1993.

93.Somers VK, Dyken ME, Clary MP, et al: Sympathetic neural mechanisms in obstructive sleep apnea. J Clin Invest 96:1897-1904, 1995.

94.Mateika JH, Mateika S, Slutsky AS, et al: The effect of snoring on mean arterial blood pressure during non-REM sleep. Am Rev Respir Dis 145:141-146, 1992.

95.Millman RP, Redline S, Carlisle CC, et al: Daytime hypertension in obstructive sleep apnea: Prevalence and contributing risk factors. Chest 99:861-866, 1991.

96.Fletcher EC, Miller J, Schaaf JW, et al: Urinary catecholamines before and after tracheostomy in patients with obstructive sleep apnea and hypertension. Sleep 10:35-44, 1987.

97.Carlson JT, Hedner J, Elam M, et al: Augmented resting sympathetic nerve activity in awake patients with obstructive sleep apnea. Chest 103:1763-1768, 1993.

98.Narkiewicz K, van de Borne PJ, Cooley RL, et al: Sympathetic activity in obese subjects with and without obstructive sleep apnea. Circulation 98:772-776, 1998.

99.Ip MS, Lam B, Chan LY, et al: Circulating nitric oxide is suppressed in obstructive sleep apnea and is reversed by nasal continuous positive airway pressure. Am J Respir Crit Care Med 162:2166-2171, 2000.

100.Imadojemu VA, Gleeson K, Quraishi SA, et al: Impaired vasodilator responses in obstructive sleep apnea are improved with continuous positive airway pressure therapy. Am J Respir Crit Care Med 165:950-953, 2002.

101.Ip MSM, Tse HF, Lam B, et al: Endothelial function in obstructive sleep apnea and response to treatment. Am J Respir Crit Care Med 169:348-353, 2004.

102.Nieto FJ, Herrington DM, Redline S, et al: Sleep apnea and markers of vascular endothelial function in a large community sample of older adults. Am J Respir Crit Care Med 169:354-360, 2004.

103.Brooks D, Horner RL, Kozar LF, et al: Obstructive sleep apnea as a cause of systemic hypertension: Evidence from a canine model. J Clin Invest 99:106-109, 1997.

104.Buda AJ, Pinsky MR, Ingels NBJ, et al: Effect of intrathoracic pressure on left ventricular performance. N Engl J Med 301:453-459, 1979.

105.Bradley TD, Holloway RM, McLaughlin PR, et al: Cardiac output response to continuous positive airway pressure in congestive heart failure. Am Rev Respir Dis 145:377-382, 1992.

106.Malone S, Liu PP, Holloway R, et al: Obstructive sleep apnoea in patients with dilated cardiomyopathy: Effects of continuous positive airway pressure. Lancet 338:1480-1484, 1991.

107.Scharf SM, Bianco JA, Tow DE, et al: The effects of large negative intrathoracic pressure on left ventricular function in patients with coronary artery disease. Circulation 63:871-875, 1981.

108.Parker JD, Brooks D, Kozar LF, et al: Acute and chronic effects of airway obstruction on canine left ventricular performance. Am J Respir Crit Care Med 160:1888-1896, 1999.

109.Buda AJ, Schroeder JS, Guilleminault C: Abnormalities of pulmonary artery wedge pressures in sleep-induced apnea. Int J Cardiol 1:67-74, 1981.

110.Peters J, Fraser C, Stuart RS, et al: Negative intrathoracic pressure decreases independently left ventricular filling and emptying. Am J Physiol 257:H120-H131, 1989.

111.Virolainen J, Ventila M, Turto H, et al: Effect of negative intrathoracic pressure on left ventricular pressure dynamics and relaxation. J Appl Physiol 79:455-460, 1995.

112.Hall MJ, Ando SI, Floras JS, et al: Magnitude and time course of hemodynamic responses to Mueller maneuvers in patients with congestive heart failure. J Appl Physiol 85:1476-1484, 1998.

113.Hanly P, Sasson Z, Zuberi N, et al: ST-segment depression during sleep in obstructive sleep apnea. Am J Cardiol 71:1341-1345, 1993.

114.Chaudhary BA, Ferguson DS, Speir WA: Pulmonary edema as a presenting feature of sleep apnea syndrome. Chest 82:122-124, 1982.

115.Chan HS, Chiu HF, Tse LK, et al: Obstructive sleep apnea presenting with nocturnal angina, heart failure, and near-miss sudden death. Chest 99:1023-1025, 1991.

116.Franklin KA, Nilsson JB, Sahlin C: Sleep apnoea and nocturnal angina. Lancet 345:1085-1087, 1995.

117.Cargill RI, Kiely DG, Lipworth BJ: Adverse effects of hypoxemia on diastolic filling in humans. Clin Sci 89:165-169, 1995.

118.Tolle FA, Judy WV, Yu PL, et al: Reduced stroke volume related to pleural pressure in obstructive sleep apnea. J Appl Physiol 55:1718-1724, 1983.

119.Stoohs R, Guilleminault C: Cardiovascular changes associated with obstructive sleep apnea syndrome. J Appl Physiol 72:583-589, 1992.

120.Somers VK, Mark AL, Zavala DC, et al: Contrasting effects of hypoxia and hypercapnia on ventilation and sympathetic activity in humans. J Appl Physiol 67:2101-2106, 1989.

121.Galatius-Jensen S, Hansen J, Rasmussen V, et al: Nocturnal hypoxaemia after myocardial infarction: Association with nocturnal myocardial ischaemia and arrhythmias. Br Heart J 72:23-30, 1994.

122.Shepard JW Jr, Garrison MW, Guther DA, et al: Relationship of ventricular ectopy to nocturnal O2 desaturation in patients with obstructive sleep apnea. Chest 88:325-340, 1985.

123.Daly PA, Sole MJ: Myocardial catecholamines and the pathophysiology of heart failure. Circulation 82(Suppl I):I-35-I-43, 1990.

124.Seppala T, Partinen M, Penttila A, et al: Sudden death and sleeping history among Finnish men. J Intern Med 229:23-28, 1991.

125.Hender J, Ejnell H, Caidahl K: Left ventricular hypertrophy independent of hypertension in patients with obstructive sleep apnea. J Hypertens 8:941-946, 1990.

126.Hanly P, Sasson Z, Zuberi N, et al: Ventricular function in snorers and patients with obstructive sleep apnea. Chest 102:100-105, 1992.

127.Amin R, Kimball T, Bean J, et al: Left ventricular hypertrophy and abnormal ventricular geometry in children and adolescents with obstructive sleep apnea. Am J Respir Crit Care Med 165:1395-1399, 2002.

128.Kaneko Y, Floras JS, Usui K, et al: Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 348:1233-1241, 2003.

129.Mansfield DR, Gollogly NC, Kaye DM, et al: Controlled trial of continuous positive airway pressure in obstructive sleep apnea and heart failure. Am J Respir Crit Care Med 169:361-366, 2004.

130.Kaye DM, Lambert GM, Lefkovits J, et al: Neurochemical evidence of cardiac sympathetic activation and increased central nervous system norepinephrine turnover in severe congestive heart failure. J Am Coll Cardiol 23:570-578, 1994.

131.Cohn JN, Levine TB, Olivary MT, et al: Plasma norepinephrine as a guide to prognosis in patients with congestive heart failure. N Engl J Med 311:819-823, 1984.

132.Sanner BM, Konermann M, Tepel M, et al: Platelet function in patients with obstructive sleep apnoea syndrome. Eur Respir J 16:648-652, 2000.

133.Bokinsky G, Miller M, Ault K, et al: Spontaneous platelet activation and aggregation during obstructive sleep apnea and its response to therapy with nasal continuous positive airway pressure: A preliminary investigation. Chest 108:625-630, 1995.

134.Nobili L, Schiavi G, Bozano E, et al: Morning increase in whole blood viscosity in obstructive sleep apnea syndrome. Clin Hemorheol Microcirc 22:21-27, 2000.

135.Shamsuzzaman AS, Winnicki M, Lanfranchi P, et al: Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 105:2462-2464, 2002.

136.Schulz R, Mahmoudi S, Hattar K, et al: Enhanced release of superoxide from polymorphonuclear neutrophils in obstructive sleep apnea: Impact of continuous positive airway pressure therapy. Am J Respir Crit Care Med 162:566-570, 2000.

137.Dyugovskaya L, Lavie P, Lavie L: Increased adhesion molecule expression and production of reactive oxygen species in leukocytes of sleep apnea patients. Am J Respir Crit Care Med 165:934-939, 2002.

138.Lavie L, Kraiczi H, Hefetz A, et al: Plasma vascular endothelial growth factor in sleep apnea syndrome: Effects of nasal continuous positive air pressure treatment. Am J Respir Crit Care Med 165:1624-1628, 2002.

139.Ip MS, Lam B, Ng MMT, et al: Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 165:670-676, 2002.

140.Punjabi NM, Sorkin JD, Karzel LI, et al: Sleep-disordered breathing and insulin resistance in middle-aged and overweight men. Am J Respir Crit Care Med 165:677-682, 2002.

141.Chin K, Shimizu K, Nakamura T, et al: Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation 100:706-712, 1999.

142.Harsch IA, Schahin SP, Radespiel-Troger M, et al: Continuous positive airway pressure treatment rapidly improves insulin sensitivity in patients with obstructive sleep apnea syndrome. Am J Respir Crit Care Med 169:156-162, 2004.

143.Bradley TD, Rutherford R, Grossman RF, et al: Role of daytime hypoxemia in the pathogenesis of right heart failure in the obstructive sleep apnea syndrome. Am Rev Respir Dis 131:835-839, 1985.

144.Weitzenblum E, Krieger J, Apprill M, et al: Daytime pulmonary hypertension in patients with obstructive sleep apnea syndrome. Am Rev Respir Dis 138:345-349, 1988.

145.Bradley TD, Rutherford R, Lue F, et al: Role of diffuse airway obstruction in the hypercapnia of obstructive sleep apnea. Am Rev Respir Dis 134:920-924, 1986.

146.Garay SM, Rapoport D, Sorkin B, et al: Regulation of ventilation in the obstructive sleep apnea syndrome. Am Rev Respir Dis 124:451-457, 1981.

147.Lopata M, Onal E: Mass loading, sleep apnea, and the pathogenesis of obesity hypoventilation. Am Rev Respir Dis 126:640-645, 1982.

148.. Loube DI, Strohl KP: Obstructive sleep apnea syndrome: Screening and diagnosis. In McNicholas WT, Phillipson EA (eds): Breathing Disorders in Sleep. London: WB Saunders, 2002, pp 86-102.

149.. Whittle AT, Finch SP, Mortimore IL, et al: Use of home sleep studies for diagnosis of the sleep apnoea/hypopnoea syndrome. Thorax 52:1068-1073, 1997.

150.. Hoffstein V: Is snoring dangerous to your health? Sleep 19:506-516, 1996.

151.. Braver HM, Block AJ, Perri MG: Treatment for snoring: Combined weight loss, sleeping on the side, and nasal spray. Chest 107:1283-1288, 1995.

152.. American Thoracic Society: Indications and standards for use of nasal continuous positive airway pressure (CPAP) in sleep apnea syndromes. Am J Respir Crit Care Med 150:1738-1745, 1994.

153.. Lévy P, Pépin JL: Management options in obstructive sleep apnea syndrome. In McNicholas WT, Phillipson EA (eds): Breathing Disorders in Sleep. London: WB Saunders, 2002, pp 105-115.

154.. Hoffstein V: Clinical significance and management of snoring without obstructive sleep apnea syndrome. In McNicholas WT, Phillipson EA (eds): Breathing Disorders in Sleep. London: WB Saunders, 2002, pp 164-178.

155.. O'Sullivan RA, Hillman DR, Mateljan R, et al: Mandibular advancement splint: An appliance to treat snoring and obstructive sleep apnea. Am J Respir Crit Care Med 151:194-198, 1995.

156.. Ferguson KA, Ono T, Lowe A, et al: A randomized cross-over trial of an oral appliance vs. nasal continuous positive airway pressure in the treatment of mild-moderate obstructive sleep apnea. Chest 109:1269-1275, 1996.

157.. Stradling JR, Negus TW, Smith D, et al: Mandibular advancement devices for the control of snoring. Eur Respir J 11:447-450, 1998.

158.. Engleman HE, Kingshott RN, Wraith PK, et al: Randomized placebo-controlled crossover trial of continuous positive airway pressure for mild sleep apnea/hypopnea syndrome. Am J Respir Crit Care Med 159:461-467, 1999.

159.. Fujita S, Conway W, Zorick F, et al: Surgical correction of anatomic abnormalities in obstructive sleep apnea syndrome: Uvulopalatopharyngoplasty. Otolaryngol Head Neck Surg 89:923-934, 1981.

160.. Kamami YV: Laser CO2 for snoring: Preliminary results. Acta Otorhinolaryngol Belg 44:451-456, 1990.

161.. Schmidt-Nowara WW, Meade TE, Hays MB: Treatment of snoring and obstructive sleep apnea with a dental orthosis. Chest 99:1378-1385, 1991.

162.. Ng AT, Gotsopoulos H, Qian J, Cistulli PA: Effect of oral appliance therapy on upper airway collapsibility in obstructive sleep apnea. Am J Respir Crit Care Med 168:238-241, 2003.

163. Sher AE, Schechtman KB, Piccirillo JF: The efficacy of surgical modifications of the upper airway in adults with obstructive sleep apnea syndrome. Sleep 19:156-177, 1996.

164.. Ryan CF, Lowe AA, Li D, et al: Three dimensional upper airway computed tomography in obstructive sleep apnea: A prospective study in patients treated by uvulopalatopharyngoplasty. Am Rev Respir Dis 144:428-432, 1991.

165.. Launois SH, Feroah TR, Campbell WN, et al: Site of pharyngeal narrowing predicts outcome of surgery for obstructive sleep apnea. Am Rev Respir Dis 147:182-189, 1993.

166.. Sullivan CE, Issa FG, Berthon-Jones M, et al: Reversal of obstructive sleep apnea by continuous positive airway pressure applied through the nares. Lancet 1:862-865, 1981.

167.. Sullivan CE, Issa FG, Berthon-Jones M, et al: Home treatment of obstructive sleep apnea with continuous positive airway pressure applied through a nose-mask. Bull Eur Physiopathol Respir 20:49-54, 1984.

168.. Hoffstein V, Viner S, Mateika S, et al: Treatment of obstructive sleep apnea with nasal continuous positive airway pressure: Patient compliance, perception of benefits, and side effects. Am Rev Respir Dis 145:841-845, 1992.

169.. McNicholas WT: Nasal continuous positive airway pressure therapy for obstructive sleep apnea syndrome. In McNicholas WT, Phillipson EA (eds): Breathing Disorders in Sleep. London: WB Saunders, 2002, pp 116-133.

170.. Becker HF, Jerrentrup A, Ploch T, et al: Effect of nasal continuous positive airway pressure treatment on blood pressure in patients with obstructive sleep apnea. Circulation 107:68-73, 2003.

171.Logan AG, Tkacova R, Perlikowski SM, et al: Refractory hypertension and sleep apnea: Effect of CPAP on blood pressure and baroreflex. Eur Respir J 21:241-247, 2003.

172.. Weitzman ED, Kahn E, Pollack CP: Quantitative analysis of sleep and sleep apnea before and after tracheostomy in patients with the hypersomnia-sleep apnea syndrome. Sleep 3:407-423, 1980.

173.. Guilleminault C, Simmons FB, Motta J, et al: Obstructive sleep apnea syndrome and tracheostomy: Long-term followup experience. Arch Intern Med 141:985-988, 1981.

174.Bradley TD, Phillipson EA: Central sleep apnea. Clin Chest Med 13:493-505, 1992.

175.. Bradley TD, McNicholas WT, Rutherford R, et al: Clinical and physiologic heterogeneity of the central sleep apnea syndrome. Am Rev Respir Dis 134:217-221, 1986.

176.Orem J: The nature of the wakefulness stimulus to breathing. Prog Clin Biol Res 345:23-31, 1990.

177.. McNicholas WT, Phillipson EA: Central hypoventilation syndromes and hypercapnic central sleep apnea. In McNicholas WT, Phillipson EA (eds): Breathing Disorders in Sleep. London: WB Saunders, 2002, pp 239-245.

178.. Bradley TD: Nonhypercapnic central sleep apnea. In McNicholas WT, Phillipson EA (eds): Breathing Disorders in Sleep. London: WB Saunders, 2002, pp 246-264.

179.. Phillipson EA: Control of breathing during sleep. Am Rev Respir Dis 118:909-939, 1978.

180.Khoo MCK, Kronauer RE, Strohl KP, et al: Factors inducing periodic breathing in humans: A general model. J Appl Physiol 53:644-659, 1982.

181.. Skatrud JB, Dempsey JA: Interaction of sleep state and chemical stimuli in sustaining rhythmic ventilation. J Appl Physiol 55:813-822, 1983.

182.186. Datta AK, Shea SA, Horner RL, et al: The influence of induced hypocapnia and sleep on the endogenous respiratory rhythm in humans. J Physiol (Lond) 440:17-33, 1991.

183.187. Khoo MCK, Gottschalk A, Pack AI: Sleep-induced periodic breathing and apnea: A theoretical study. J Appl Physiol 70:2014-2024, 1991.

184.Berssenbrugge A, Dempsey J, Iber C, et al: Mechanisms of hypoxia-induced periodic breathing during sleep in humans. J Physiol (Lond) 343:507-524, 1983.

185.. Lahiri S, Maret K, Sherpa MG: Dependence of high altitude sleep apnea on ventilatory sensitivity to hypoxia. Respir Physiol 52:281-301, 1983.

186.. Weil JV: Sleep at high altitude. Clin Chest Med 6:615-621, 1985.

187.. Javaheri S, Parker TJ, Liming JD, et al: Sleep apnea in 81 ambulatory male patients with stable heart failure. Circulation 97:2154-2159, 1998.

188.. Sin DD, Fitzgerald F, Parker JD, et al: Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 160:1101-1106, 1999.

189.. Naughton M, Benard D, Tam A, et al: Role of hyperventilation in the pathogenesis of central sleep apneas in patients with congestive heart failure. Am Rev Respir Dis 148:330-338, 1993.

190.. Lorenzi-Filho G, Rankin F, Bies I, et al: Effects of inhaled carbon dioxide and oxygen on Cheyne-Stokes respiration in patients with heart failure. Am J Respir Crit Care Med 159:1490-1498, 1999.

191.. Xie A, Wong B, Phillipson EA, et al: Interaction of hyperventilation and arousal in the pathogenesis of idiopathic central sleep apnea. Am J Respir Crit Care Med 150:489-495, 1994.

192.. Javaheri S: A mechanism of central sleep apnea in patients with heart failure. N Engl J Med 341:949-954, 1999.

193.. Tkacova R, Hall MJ, Liu PP, et al: Left ventricular volume in patients with heart failure and Cheyne-Stokes respiration during sleep. Am J Respir Crit Care Med 156:1549-1555, 1997.

194.Solin P, Bergin P, Richardson M, et al: Influence of pulmonary capillary wedge pressure on central apnea in heart failure. Circulation 99:1574-1579, 1999.

195.Solin P, Roebuck T, Johns DP, et al: Peripheral and central ventilatory responses in central sleep apnea with and without congestive heart failure. Am J Respir Crit Care Med 162:2194-2200, 2000.

196.. Churchill ED, Cope O: The rapid shallow breathing resulting from pulmonary congestion and edema. J Exp Med 49:531-537, 1929.

197.Xie A, Rankin F, Rutherford R, et al: Effects of inhaled CO2 and added dead space on idiopathic central sleep apnea. J Appl Physiol 82:918-926, 1997.

198.Naughton MT, Liu PP, Bernard DC, et al: Treatment of congestive heart failure and Cheyne-Stokes respiration during sleep by continuous positive airway pressure. Am J Respir Crit Care Med 151:92-97, 1995.

199.van de Borne P, Oren R, Abouassaly C, et al: Effect of Cheyne-Stokes respiration on muscle sympathetic nerve activity in severe congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol 81:432-436, 1998.

200.Naughton MT, Benard DC, Liu PP, et al: Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. Am J Respir Crit Care Med 152:473-479, 1995.

201.Bradley TD: Right and left ventricular functional impairment and sleep apnea. Clin Chest Med 13:459-479, 1992.

202.Harrison TR, King CE, Calhoun JA, et al: Cheyne-Stokes respiration as the cause of paroxysmal dyspnea at the onset of sleep. Arch Intern Med 53:891-910, 1934.

203.Hanly PJ, Millar TW, Steljes DG, et al: Respiration and abnormal sleep in patients with congestive heart failure. Chest 96:480-488, 1989.

204.Dowdell WT, Javaheri S, McGinnis W: Cheyne-Stokes respiration presenting as sleep apnea syndrome: Clinical and polysomnographic features. Am Rev Respir Dis 141:871-879, 1990.

205.. Javaheri S, Corbett WS: Association of low PaCO2 with central sleep apnea and ventricular arrhythmias in ambulatory patients with stable heart failure. Ann Intern Med 128:204-207, 1998.

206.Goldman S, Johnson G, Cohn JN, et al: Mechanism of death in heart failure: The vasodilator-heart failure trials. Circulation 87(Suppl VI):VI-24-VI-31, 1993.

207.. Hanly PJ, Zuberi-Khokhar NS: Increased mortality associated with Cheyne-Stokes respiration in patients with congestive heart failure. Am J Respir Crit Care Med 153:272-276, 1996.

208.Sutton FD Jr, Zwillich CW, Creagh CE, et al: Progesterone for outpatient treatment of Pickwickian syndrome. Ann Intern Med 83:476-479, 1975.